Pot Stocks to Watch; (OTCQX: $AAWH; CSE: $AAWH-U.CN)
(NASDAQ: $ISPR) (NASDAQ: $SHFS) (NASDAQ: $KDLY) (NASDAQ: $MIRA) (OTCQX: $AVCNF;
TSX: $AVCN.TO)
August 9, 2024 –
(Investorideas.com Newswire) Investorideas.com, a global news source and expert investing
resource, announces today’s roundup of stocks in the cannabis/psychedelic
sector.
The newest cannabis
companies are involved in cultivating cannabis products for retail and
wholesale, cannabis vaping products, providing banking services to
cannabis, hemp, CBD operators, alternative pain treatment centers using medical
cannabis and treatment of neurologic and
neuropsychiatric disorders using a Ketamine anolog.
Read this in full at https://www.investorideas.com/news/2024/main/08091Stocks.asp
Investor Ideas is always researching and searching
for new stocks to add to our growing list of free stock directories. The
directories are not meant as recommendations but as a research tool to discover
opportunities and trading ideas in a particular sector.”
New Stocks Added to the Cannabis Directories:
Ascend
Wellness Holdings Inc. (OTCQX: AAWH; CSE: AAWH-U)
is a vertically integrated operator with assets in Illinois, Maryland,
Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. AWH owns and
operates state-of-the-art cultivation facilities, growing award-winning strains
and producing a curated selection of products for retail and wholesale
customers. AWH produces and distributes its in-house Common Goods, Simply Herb,
Ozone, Ozone Reserve, Tunnel Vision, and Royale branded products.
Ispire Technology
Inc. (NASDAQ: ISPR)
is engaged in the research and development, design, commercialization, sales,
marketing and distribution of branded e-cigarettes and cannabis vaping
products. The Company's operating subsidiaries own or license more than 400
patents worldwide. Ispire's branded e-cigarette products are marketed under the
Aspire name and are sold worldwide (except in the U.S., People's Republic of
China and Russia) primarily through its global distribution network. The
Company also engages in original design manufacture (ODM) relationships with
e-cigarette brands and retailers worldwide. The Company's cannabis products are
marketed under the Ispire brand name primarily on an ODM basis to other
cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US,
Europe and South Africa, it also has commenced marketing activities and
customer engagement in Canada and Latin America.
SHF Holdings, Inc.
d/b/a Safe Harbor Financial (NASDAQ: SHFS)
is among the first service providers to offer compliance, monitoring and
validation services to financial institutions, providing traditional banking
services to cannabis, hemp, CBD, and ancillary operators, making communities
safer, driving growth in local economies, and fostering long-term partnerships.
Safe Harbor, through its financial institution clients, implements high
standards of accountability, transparency, monitoring, reporting and risk
mitigation measures while meeting Bank Secrecy Act obligations in line with
FinCEN guidance on cannabis-related businesses. Over the past nine years, Safe
Harbor has facilitated more than $21 billion in deposit transactions for
businesses with operations spanning over 41 states and US territories with
regulated cannabis markets.
Kindly MD (NASDAQ: KDLY)
is a patient-first healthcare and healthcare data company uniquely integrating
traditional primary care and pain management strategies with integrated behavioral
and alternative therapies to offer patients comprehensive care and reduce the
addiction and dependency of opioid use in the U.S. KindlyMD currently operates
four centers including the largest alternative pain treatment center in Utah.
With a focus on holistic pain management through its specialty outpatient
clinical services, including, where appropriate, the recommendation of medical
cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient
health outcomes.
MIRA
Pharmaceuticals, Inc. (NASDAQ:MIRA) is a pre-clinical-stage pharmaceutical development company
with two neuroscience programs targeting a broad range of neurologic and
neuropsychiatric disorders. MIRA holds the exclusive U.S., Canadian and Mexican
rights for Ketamir-2, a novel, patent pending oral ketamine analog under
investigation to potentially deliver ultra-rapid antidepressant effects,
providing hope for individuals battling treatment-resistant depression, major
depressive disorder with suicidal ideation and post-traumatic stress disorder.
The U.S. Drug Enforcement Administration's scientific review of Ketamir-2
concluded that it would not be considered a controlled substance or listed
chemical under the Controlled Substances Act and its governing regulations. In
addition, MIRA's novel oral pharmaceutical marijuana analog, MIRA-55, is
currently under investigation for treating adult patients suffering from
neuropathic pain as well as anxiety and cognitive decline, often associated
with early-stage dementia. MIRA-55, if approved by the FDA, could mark a
significant advancement in addressing various neuropsychiatric, inflammatory,
and neurologic diseases and disorders. The U.S. Drug Enforcement
Administration's scientific review of MIRA-55 concluded that it would not be
considered a controlled substance or listed chemical under the Controlled
Substances Act and its governing regulations.
Avicanna Inc. (OTCQX: AVCNF; TSX: AVCN) is a commercial-stage
international biopharmaceutical company focused on the advancement and
commercialization of cannabinoid-based products and formulations for the global
medical and pharmaceutical market segments. Avicanna has an established
scientific platform including R&D and clinical development leading to the
commercialization of more than thirty proprietary, evidence-based finished
products and supporting four commercial stage business pillars.
Investor Ideas does not
condone the use of cannabis except where permissible by law. Our site does not
possess, distribute, or sell cannabis products.
Get more Cannabis
Stock Investor Ideas - news,
articles, podcasts and stock directories
About
Investorideas.com
Investorideas.com is the
go-to platform for big investing ideas. From breaking stock news to top-rated
investing podcasts, we cover it all. Our original branded content includes
podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and
the AI Eye. We also create free investor stock directories for various sectors,
including gaming, biotech, tech and sports. Public companies within the sectors
we cover can use our news publishing and content creation services to help tell
their story to interested investors. Paid content is always disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media,
podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com to be added to our stock directories or learn more about us
Dawn Van Zant and Cali Van Zant
800
665 0411
No comments:
Post a Comment